'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Nidan Laboratories and Healthcare Limited
NIDAN (NSE) · ISIN INE0J6L01013 · Healthcare Service Provider · listed 2021
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹69.69 cr | ₹11.16 cr | ₹84 cr |
| 30 Sep 2025 standalone | ₹69.62 cr | ₹12.5 cr | ₹85.76 cr |
| 31 Mar 2025 standalone | ₹68.18 cr | ₹11.11 cr | ₹82.94 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 57.04% | 0.00% | 0.00% | 42.96% |
Latest filings
- Annual Report FY2025-26 (New) 2 September 2026 · NSE
- Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 20, 2026. 20 August 2026 · NSE
- Nidan Laboratories And Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. 25 May 2026 · NSE
- Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Board meeting held on February 05, 2026. 5 February 2026 · NSE
- Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Board meeting held on November 10, 2025. 10 November 2025 · NSE
Other companies in Healthcare Service Provider
- Dr. Lal Path Labs Ltd.
- Metropolis Healthcare Limited
- Thyrocare Technologies Limited
- Vijaya Diagnostic Centre Limited
- Krsnaa Diagnostics Limited
- One Global Service Provider Limited
- Nephrocare Health Services Limited
- Suraksha Diagnostic Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.